Covered recipient · General Payments record
SAMANTHA QUINN
General Payments · PY2022–2024
$781.53
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.75 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kaleo, Inc. | $53.83 | 3 |
| Corium, Inc. | $44.24 | 2 |
| Tris Pharma Inc | $36.06 | 2 |
| Verrica Pharmaceuticals Inc. | $33.89 | 2 |
| Merck Sharp & Dohme Corporation | $33.31 | 2 |
| Neos Therapeutics, LP | $20.28 | 1 |
| GlaxoSmithKline, LLC. | $19.52 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.93 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $17.14 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100208196 | CMS |
| Corium, LLC | $27.10 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100208198 | CMS |
| GlaxoSmithKline, LLC. | $19.52 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116163514 | CMS |
| kaleo, Inc. | $15.13 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126634397 | CMS |
| kaleo, Inc. | $20.87 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126634399 | CMS |
| kaleo, Inc. | $17.83 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126634401 | CMS |
| Merck Sharp & Dohme LLC | $16.04 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141815065 | CMS |
| Merck Sharp & Dohme LLC | $17.27 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141947849 | CMS |
| Neos Therapeutics, LP | $20.28 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082669343 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.69 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139994205 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.93 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811182 | CMS |
| Tris Pharma Inc | $21.31 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147221838 | CMS |
| Tris Pharma Inc | $14.75 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147221836 | CMS |
| Verrica Pharmaceuticals Inc. | $18.50 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118396014 | CMS |
| Verrica Pharmaceuticals Inc. | $15.39 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118396016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.